← Leaderboards
Prabhas V Moghe
Rutgers, The State Univ Of N.J.
$4,221,346
Attributed
$10,204,237
Total exposure
8
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2009–24$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$10,204,237 · 8
By mechanism
R01$7,060,625 · 2
R21$2,382,089 · 5
T32$761,523 · 1
Top collaborators
- Mark Pierce7 shared
- Richard E Riman6 shared
- Charles M. Roth6 shared
- Kathryn Elizabeth Uhrich5 shared
- Vidya Ganapathy4 shared
- Zhiping P. Pang4 shared
- Mei Chee Tan4 shared
- Joachim B. Kohn2 shared
Most similar at Rutgers, The State Univ Of N.J.
Same institution · by research overlap
- Vidya Ganapathy$644,328
- Mei Chee Tan$644,328
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroDesignIn VivoInnovationBaseNanoparticleCellsBlood VesselsEngineeringLeadBiologicalExhibitsSurfaceMolecularCardiovascular DiseasesGenerationsMouse Model3-DimensionalPhenotypeTissuesNerve DegenerationNanoprobePathologyEndothelium
Grant awards (25)
Nanotechnology for Glial Targeting and Inhibition of Neuroinflammation for Alzheimerâs Disease$445,625
R21 · FY2024 · AG · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$668,896
R01 · FY2022 · EB · contact PI
Rare earth nanoprobes for optical imaging and disease tracking (C3i)$154,769
R01 · FY2022 · EB · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$636,436
R01 · FY2020 · EB · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$633,911
R01 · FY2019 · EB · contact PI
Postdoctoral Training for Translating Research in Regenerative Medicine$362,692
T32 · FY2019 · EB
Microglial-Targeted Nanotherapeutics for Inhibition of Alpha-Synuclein Aggregation and Inflammation in Neurodegenerative Diseases$191,275
R21 · FY2019 · AG · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$638,068
R01 · FY2018 · EB · contact PI
Postdoctoral Training for Translating Research in Regenerative Medicine$398,831
T32 · FY2018 · EB
Microglial-Targeted Nanotherapeutics for Inhibition of Alpha-Synuclein Aggregation and Inflammation in Neurodegenerative Diseases$243,623
R21 · FY2018 · AG · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$507,926
R01 · FY2017 · EB · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$510,980
R01 · FY2016 · EB · contact PI
Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons$232,500
R21 · FY2016 · NS · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$497,424
R01 · FY2015 · EB · contact PI
Nanofibrous Scaffolds for Transplantation of Human Dopaminergic Neurons$191,000
R21 · FY2015 · NS · contact PI
RARE EARTH NANOPROBES FOR OPTICAL IMAGING AND DISEASE TRACKING$553,271
R01 · FY2014 · EB · contact PI
Synthetic Counter-ligands for Inhibition of Atherosclerosis$528,094
R01 · FY2014 · HL · contact PI
Synthetic Counter-ligands for Inhibition of Atherosclerosis$502,386
R01 · FY2013 · HL · contact PI
Albumin-Encapsulated Rare Earth Nanoprobes for Multifunctional Tissue Imaging$216,395
R21 · FY2013 · EB · contact PI
Synthetic Counter-ligands for Inhibition of Atherosclerosis$613,682
R01 · FY2012 · HL · contact PI
Albumin-Encapsulated Rare Earth Nanoprobes for Multifunctional Tissue Imaging$190,652
R21 · FY2012 · EB · contact PI
Synthetic Counter-ligands for Inhibition of Atherosclerosis$614,782
R01 · FY2011 · HL · contact PI
Nanoscale Receptor Blockers for Inhibition of Atherosclerosis$190,950
R21 · FY2010 · HL · contact PI
Nanoscale Receptor Blockers for Inhibition of Atherosclerosis$254,400
R21 · FY2009 · HL · contact PI
Nanoscale Receptor Blockers for Inhibition of Atherosclerosis$225,669
R21 · FY2009 · HL · contact PI